RASD1 and adrenal cortex carcinoma: The expression of RASD1 inversely correlated to survival outcomes in Adrenocortical carcinoma (ACC), Bladder Urothelial Carcinoma (BLCA), and Mesothelioma (MESO) (Figure 5b–d).